Some studies reported the expression level of PD-1 in tumors, including NPC, hepatic-cellular cancer, breast cancer, renal cell carcinoma, non-small cell lung carcinoma (NSCLC), high-grade serous carcinoma, and so on [16–20]. Here, PDCD1 is linked to nasopharyngeal carcinoma.